Product Information

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB is a generic product labeled by Padagis US LLC, priced at $0.2536 per EA under NDC 00574022801. Its NADAC has been published 380 times since May 15, 2019.

FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB

benazepril hydrochloride and hydrochlorothiazide
$0.2536per EA

Strength

20; 25 mg/1; mg/1

Manufacturer

Padagis US LLC

NDC

00574022801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020033

FDA Approved

5/19/1992

TE Code

AB

On Market Since

4/7/2019

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has been published 380 times since May 15, 2019, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2536 per EA
All-time high$0.7238 (Oct 16, 2019)
All-time low$0.1769 (Jul 17, 2024)
52-week high$0.2536
52-week low$0.2226
Median price$0.4545
Average price$0.4446
Largest weekly change+61.1% (Aug 21, 2024)
Weeks tracked380
Tracking sinceMay 15, 2019

Price History

1W

+2.3%

1M

+2.3%

3M

+12.3%

6M

+9.3%

1Y

+4.6%

3Y

-41.3%

5Y

-53.0%

All

-64.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, manufactured by Padagis US LLC, is $0.2536 per EA (NDC 00574022801), effective Aug 19, 2026.

How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB changed over time?

Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has declined 64.0%. It has been tracked across 380 weekly CMS publications since May 15, 2019.

What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

Since May 15, 2019, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has ranged from a low of $0.1769 (Jul 17, 2024) to a high of $0.7238 (Oct 16, 2019), with a median of $0.4545 per EA.

Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?

BENAZEPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB (NDC 00574022801) is labeled by Padagis US LLC, and CMS classifies it as a generic product.